We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Digital PCR Platform Harnesses Microfluidic Technology for Quantification of Genetic Targets

By LabMedica International staff writers
Posted on 03 Apr 2023
Print article
Image: The naica system for Crystal Digital PCR (Photo courtesy of Stilla Technologies)
Image: The naica system for Crystal Digital PCR (Photo courtesy of Stilla Technologies)

Digital PCR (dPCR) is a powerful method that enables the precise and ultra-sensitive measurement of nucleic acids. This technique offers enhanced accuracy and sensitivity for detecting low-level abundance nucleic acids in the case of bacterial and viral pathogens, resulting in absolute quantification and remarkable specificity. Although qPCR has been the go-to technique for pathogen detection, dPCR provides superior accuracy in the presence of inhibitors and does not require a standard curve for absolute quantification. Now, an easy-to-use dPCR platform harnesses cutting-edge microfluidic technology to integrate the dPCR workflow onto a single consumable chip, resulting in higher sensitivity and accuracy when detecting low-level abundance nucleic acids in the detection of bacterial and viral pathogens.

The naica system from Stilla Technologies (Villejuif, France) harnesses the key principles of digital PCR and is designed to provide a sensitive, fast, and easy-to-use platform for the quantification of genetic targets. It boasts the highest multiplexing capacity currently offered in the market for the simultaneous detection and quantification of multiple genetic targets in a single run. The naica system is based on Stilla’s Crystal Digital PCR technology that partitions samples into a large array of thousands of individual droplet crystals – each its own reaction compartment – before amplifying nucleic acid molecules in each droplet crystal. These reactions are tagged with fluorophores to be read using up to six different fluorescence light channels. This results in a fast and simple workflow that delivers high multiplexing capability with exceptional sensitivity while reducing time-to-results and conserving valuable samples.

The naica system simplifies any digital PCR application by combining high multiplexing assay design compatibility and powerful imaging with the flexibility to use up to six detection channels and proprietary software for analysis. Crystal Miner, the naica system’s proprietary software, offers intuitive visuals for image analysis, enabling thorough exploration of Droplet Crystals for quality control. Crystal Miner measures the concentrations of targeted nucleic acids, enabling automatic identification of positive and negative droplets for all fluorescence channels. The naica system requires minimal technical expertise, as it comes with optimized digital PCR reagents that are ready to use, simple pipetting steps, and chip consumables that are ready for partitioning, amplification, and read-out. Assays can be run with just a few minutes of actual hands-on time, making the naica system highly efficient and user-friendly.

Related Links:
Stilla Technologies 

New
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Blood Culture Identification Fungal Pathogen Panel
cobas eplex BCID-FP panel
New
Cooling Table Centrifuge
MPW-352R

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The PAXgene Urine Liquid Biopsy Set is the first standardized preanalytical workflow that stabilizes cell-free DNA in urine for subsequent analysis (Photo courtesy of PreAnalytiX)

Liquid Biopsy Solution Enables Non-Invasive Sample Collection and Direct Cell-Free DNA Stabilization from Urine

Urine cell-free DNA (cfDNA) presents significant potential for research and future clinical applications. It facilitates the measurement and analysis of cfDNA fragments, detection of genetic alterations,... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.